Brianna’s position as the life sciences audit policy leader is a dual role involving industry-specific audit technical leadership as well as client service. In her national level position, her outreach extends throughout the firm—far beyond her seat in the Boston office—and fosters relationships with life sciences specialists nationwide and internationally.
As the life sciences audit policy leader, she provides counsel regarding emerging industry-related audit and accounting issues. She prepares communications, tools and guidance on technical subject matters for publication internally throughout the firm and externally to clients.
Her clients consist of companies in the life sciences sector—specifically biopharma, medical devices, life science services and clinical research organizations—and vary in maturity from early-stage companies raising their initial equity through large multinational companies.
She has extensive experience working with private equity group portfolio companies, assisting in business combinations, complex debt and equity financings, and revenue recognition matters. Brianna’s client services include mergers and acquisitions, consultations and analysis, and assisting early-stage companies in raising their initial capital. She advises clients on accounting and financial reporting matters, as well as business and industry issues.
Brianna is passionate about the life sciences industry and all its contributions to lifesaving drugs and medical devices. She is energized by how her clients bring innovative therapies and devices to patients and improve people's lives by delivering new solutions to everyday medical challenges.
Outside of RSM, Brianna enjoys spending time with her husband and sons, as well as running, cooking and sitting down with a good book.
